We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
The Zacks Analyst Blog Highlights Costco Wholesale, Alibaba, GE Aerospace, Applied Energetics and NeurAxis
Read MoreHide Full Article
For Immediate Release
Chicago, IL – September 25, 2024 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Costco Wholesale Corp. (COST - Free Report) , Alibaba Group Holding Ltd. (BABA - Free Report) , GE Aerospace (GE - Free Report) , Applied Energetics, Inc. (AERG - Free Report) and NeurAxis, Inc. (NRXS - Free Report) .
Here are highlights from Tuesday’s Analyst Blog:
Top Analyst Results for Costco, Alibaba and GE Aerospace
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Costco Wholesale Corp., Alibaba Group Holding Ltd. and GE Aerospace, as well as two micro-cap stocks Applied Energetics, Inc. and NeurAxis, Inc.. The Zacks microcap research is unique as our research content on these small and under-the-radar companies is the only research of its type in the country.
These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
Costco Wholesale's shares have outperformed the Zacks Retail - Discount Stores industry over the year-to-date period (+39.6% vs. +23.5%). The company being a consumer defensive stock, has been surviving the market turmoil pretty well. The discount retailer's key strengths are strategic investments, a customer-centric approach, merchandise initiatives, and an emphasis on membership growth. These factors have been helping it register decent sales and earnings numbers.
The Zacks analyst expects the company to register 8.6% adjusted earnings per share improvement in fiscal 2024 on 4.8% revenue growth. This outlook reflects Costco's ability to navigate the challenging operating environment, generate solid sales, and register high membership renewal rates.
A favorable product mix, steady store traffic, pricing power, and strong liquidity position should help Costco keep outperforming. While trading at a premium to its peers, its long-term growth prospects should help the stock see a solid upside.
Shares of Alibaba have outperformed the Zacks Internet - Commerce industry over the year-to-date period (+26.7% vs. +23.8%). The company is benefiting from strong momentum in its international commerce retail business, driven by strength in AliExpress' Choice. Growing international commerce wholesale business, thanks to strength in cross-border-related value-added services, is a tailwind.
Expanding China's wholesale commerce business is a positive. Robust local consumer services and Cainiao logistics services are further driving top-line growth. Strength in Lazada, AliExpress and Trendyol is expected to continue benefiting Alibaba's international business. Solid adoption of public cloud products remains a plus.
However, rising expenses related to new initiatives, and sluggish China commerce retail business are a concern. Macroeconomic uncertainties and unfavorable foreign exchange fluctuations are risks.
Shares of GE Aerospace have outperformed the Zacks Transportation - Airline industry over the past six months (+36.8% vs. +17.3%). The company has been witnessing strength in its businesses, driven by robust demand for commercial engines, propulsion and additive technologies. Rising U.S. & international defense budgets, geopolitical tensions, positive airline & airframer dynamics and robust demand for commercial air travel augur well for the company.
GE Aerospace remains committed to making investments to boost growth and provide better services to its customers. Its portfolio-reshaping actions are likely to unlock values for its shareholders. Its shareholder-friendly policies are encouraging.
For 2024, it expects organic revenues to grow in the high-single-digit range from the year-ago level. However, it has been dealing with high costs and expenses related to projects and restructuring activities.
Applied Energetics' shares have underperformed the Zacks Lasers Systems and Components industry over the past year (-58.0% vs. -17.5%). This microcap company with market capitalization of $196.66 million is facing high operating losses, reliance on government contracts, legal risks and limited commercial revenue are significant risks. Despite raising $4.17 million in the first half of 2024, ongoing cash burn and competition from established defense contractors present challenges to achieving profitability.
Nevertheless, Applied Energetics is positioned as a leader in the directed energy market, with its USPL offering a powerful solution for countering ISR threats. The company's USPL technology, backed by 25 issued patents, is ideal for military applications like counter-UAS systems.
Multiple contracts with the key U.S. military branches, scalable and efficient designs, and the potential for commercial market expansion (advanced manufacturing, biomedical imaging) create growth opportunities for the company.
Shares of NeurAxis have underperformed the Zacks Medical Info Systems industry over the past year (-23.3% vs. +6.8%). This microcap company with market capitalization of $19.84 million is facing operational losses and a high cash burn rate. Risks include dependency on insurance adoption, regulatory approval timelines and competitive pressures in the MedTech space.
Nevertheless, NeurAxis has expanded insurance coverage for its IB-Stim device from 4.5 million lives in May 2023 to 22.5 million in June 2024, with expectations to exceed 50 million by the year-end. This expansion addresses a key revenue barrier, with accelerated growth anticipated as more insurers adopt coverage.
Supported by clinical data and 16 peer-reviewed publications and endorsements from the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN), NeurAxis aims to achieve profitability by early 2025, fueled by rising unit sales and a robust pipeline,
Since 2000, our top stock-picking strategies have blown away the S&P's +7.0 average gain per year. Amazingly, they soared with average gains of +44.9%, +48.4% and +55.2% per year.
Today you can access their live picks without cost or obligation.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
The Zacks Analyst Blog Highlights Costco Wholesale, Alibaba, GE Aerospace, Applied Energetics and NeurAxis
For Immediate Release
Chicago, IL – September 25, 2024 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Costco Wholesale Corp. (COST - Free Report) , Alibaba Group Holding Ltd. (BABA - Free Report) , GE Aerospace (GE - Free Report) , Applied Energetics, Inc. (AERG - Free Report) and NeurAxis, Inc. (NRXS - Free Report) .
Here are highlights from Tuesday’s Analyst Blog:
Top Analyst Results for Costco, Alibaba and GE Aerospace
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Costco Wholesale Corp., Alibaba Group Holding Ltd. and GE Aerospace, as well as two micro-cap stocks Applied Energetics, Inc. and NeurAxis, Inc.. The Zacks microcap research is unique as our research content on these small and under-the-radar companies is the only research of its type in the country.
These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
You can see all of today's research reports here >>>
Costco Wholesale's shares have outperformed the Zacks Retail - Discount Stores industry over the year-to-date period (+39.6% vs. +23.5%). The company being a consumer defensive stock, has been surviving the market turmoil pretty well. The discount retailer's key strengths are strategic investments, a customer-centric approach, merchandise initiatives, and an emphasis on membership growth. These factors have been helping it register decent sales and earnings numbers.
The Zacks analyst expects the company to register 8.6% adjusted earnings per share improvement in fiscal 2024 on 4.8% revenue growth. This outlook reflects Costco's ability to navigate the challenging operating environment, generate solid sales, and register high membership renewal rates.
A favorable product mix, steady store traffic, pricing power, and strong liquidity position should help Costco keep outperforming. While trading at a premium to its peers, its long-term growth prospects should help the stock see a solid upside.
(You can read the full research report on Costco Wholesale here >>>)
Shares of Alibaba have outperformed the Zacks Internet - Commerce industry over the year-to-date period (+26.7% vs. +23.8%). The company is benefiting from strong momentum in its international commerce retail business, driven by strength in AliExpress' Choice. Growing international commerce wholesale business, thanks to strength in cross-border-related value-added services, is a tailwind.
Expanding China's wholesale commerce business is a positive. Robust local consumer services and Cainiao logistics services are further driving top-line growth. Strength in Lazada, AliExpress and Trendyol is expected to continue benefiting Alibaba's international business. Solid adoption of public cloud products remains a plus.
However, rising expenses related to new initiatives, and sluggish China commerce retail business are a concern. Macroeconomic uncertainties and unfavorable foreign exchange fluctuations are risks.
(You can read the full research report on Alibaba here >>>)
Shares of GE Aerospace have outperformed the Zacks Transportation - Airline industry over the past six months (+36.8% vs. +17.3%). The company has been witnessing strength in its businesses, driven by robust demand for commercial engines, propulsion and additive technologies. Rising U.S. & international defense budgets, geopolitical tensions, positive airline & airframer dynamics and robust demand for commercial air travel augur well for the company.
GE Aerospace remains committed to making investments to boost growth and provide better services to its customers. Its portfolio-reshaping actions are likely to unlock values for its shareholders. Its shareholder-friendly policies are encouraging.
For 2024, it expects organic revenues to grow in the high-single-digit range from the year-ago level. However, it has been dealing with high costs and expenses related to projects and restructuring activities.
(You can read the full research report on GE Aerospace here >>>)
Applied Energetics' shares have underperformed the Zacks Lasers Systems and Components industry over the past year (-58.0% vs. -17.5%). This microcap company with market capitalization of $196.66 million is facing high operating losses, reliance on government contracts, legal risks and limited commercial revenue are significant risks. Despite raising $4.17 million in the first half of 2024, ongoing cash burn and competition from established defense contractors present challenges to achieving profitability.
Nevertheless, Applied Energetics is positioned as a leader in the directed energy market, with its USPL offering a powerful solution for countering ISR threats. The company's USPL technology, backed by 25 issued patents, is ideal for military applications like counter-UAS systems.
Multiple contracts with the key U.S. military branches, scalable and efficient designs, and the potential for commercial market expansion (advanced manufacturing, biomedical imaging) create growth opportunities for the company.
(You can read the full research report on Applied Energetics here >>>)
Shares of NeurAxis have underperformed the Zacks Medical Info Systems industry over the past year (-23.3% vs. +6.8%). This microcap company with market capitalization of $19.84 million is facing operational losses and a high cash burn rate. Risks include dependency on insurance adoption, regulatory approval timelines and competitive pressures in the MedTech space.
Nevertheless, NeurAxis has expanded insurance coverage for its IB-Stim device from 4.5 million lives in May 2023 to 22.5 million in June 2024, with expectations to exceed 50 million by the year-end. This expansion addresses a key revenue barrier, with accelerated growth anticipated as more insurers adopt coverage.
Supported by clinical data and 16 peer-reviewed publications and endorsements from the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN), NeurAxis aims to achieve profitability by early 2025, fueled by rising unit sales and a robust pipeline,
(You can read the full research report on NeurAxis here >>>)
Why Haven't You Looked at Zacks' Top Stocks?
Since 2000, our top stock-picking strategies have blown away the S&P's +7.0 average gain per year. Amazingly, they soared with average gains of +44.9%, +48.4% and +55.2% per year.
Today you can access their live picks without cost or obligation.
See Stocks Free >>
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
support@zacks.com
https://www.zacks.com
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.